Long-term outcomes data from ADVANCE-DK Registry with HeartFlow FFRCT and Plaque Analysis and ongoing clinical studies highlighting CCTA and FFRCT diagnostic pathway to be discussed in six presentations
Author: Ken Dropiewski
Transverse Medical Appoints Former Boston Scientific EVP and Global Chief Medical Officer, Professor Ian T. Meredith, to Board of Directors
DENVER–(BUSINESS WIRE)–Transverse Medical, Inc., developer of the POINT-GUARD™ Cerebral Embolic Protection medical device, is pleased to announce the appointment of Ian T. Meredith, MD to the Board of Directors. Professor Meredith brings over 35 years of experience and global leadership […]
Johnson & Johnson Completes Acquisition of V-Wave
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson1 (NYSE: JNJ) announced today it has successfully completed the acquisition of V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. V-Wave will operate as part of Johnson & […]
Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination
TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) — Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“the “Resulting Issuer” or the “Corporation”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the previously announced business combination between Conavi Medical Inc. (“Conavi”) and the Corporation in an all-stock transaction, which constituted a reverse takeover of the Corporation (the “Transaction”). The combined company (the Resulting Issuer) will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.
HeartFlow Announces Favorable Coverage Determination for Plaque Analysis by Four Medicare Administrative Contractors
Coverage policy improves access to artificial intelligence-enabled plaque analysis providing insights to help physicians guide treatment decisions for patients with coronary artery disease Coverage policy improves access to artificial intelligence-enabled plaque analysis providing insights to help physicians guide treatment decisions for patients with coronary artery disease
Cardiac Surgeons at Pittsburgh’s Allegheny General Hospital First in the State to Successfully Implant New Device to Repair Leaky Tricuspid Heart Valve
Tricuspid valve regurgitation can lead to enlarged heart, fatigue and heart failure; the condition affects 1.6 million Americans PITTSBURGH, Oct. 10, 2024 /PRNewswire-PRWeb/ — The cardiac team from Allegheny General Hospital (AGH), the academic flagship facility of Allegheny Health…
Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping
Enrollment completed ahead of schedule in the global IDE for Abbott’s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott’s TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™, receives U.S. Food and Drug Administration…
Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous Thromboembolism
Campaign is led by prominent medical societies to minimize discrepancies in treating blood clot conditions, such as in pulmonary embolism, where there are often delays in care (up to 26% of patients in one study) and misdiagnosis (up to 53% of patients in one study)1,2 ALAMEDA, Calif.,…
First Pediatric Heart Transplant in Decades Performed at Oklahoma Children’s Hospital OU Health
OKLAHOMA CITY, Oct. 9, 2024 /PRNewswire/ — OU Health, the flagship academic health system of the University of Oklahoma, has performed its first pediatric heart transplant in decades at Oklahoma Children’s Hospital OU Health, marking a significant milestone in pediatric cardiac care for…
Medtronic launches the Avalus Ultra™ valve in Western Europe at the European Association for Cardio-Thoracic Surgery (EACTS) Congress
Medtronic plc, a global leader in healthcare technology, today announced the launch of the Avalus Ultra™ Bioprosthesis valve in Western Europe during the EACTS annual congress in Lisbon. The Avalus Ultra valve, engineered for ease of use at implant and […]
Recent
VS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study POWER PAD II IDE trial will evaluate safety and efficacy of the Pulse IVL™ system in patients with severely calcified peripheral arterial disease
NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
Popular
- No commented posts yet